OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1299-1299
Open Access | Times Cited: 14
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1299-1299
Open Access | Times Cited: 14
Showing 14 citing articles:
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer
Tira J. Tan, Sarah Sammons, Young‐Hyuck Im, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 7, pp. 1240-1247
Open Access | Times Cited: 12
Tira J. Tan, Sarah Sammons, Young‐Hyuck Im, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 7, pp. 1240-1247
Open Access | Times Cited: 12
Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
Rámón Colomer, Blanca González‐Farré, Ana Isabel Ballesteros, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 12, pp. 2935-2951
Open Access | Times Cited: 3
Rámón Colomer, Blanca González‐Farré, Ana Isabel Ballesteros, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 12, pp. 2935-2951
Open Access | Times Cited: 3
Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer
Zheng Wang, Yujie Lu, Mengyuan Han, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 2, pp. 429-440
Open Access | Times Cited: 2
Zheng Wang, Yujie Lu, Mengyuan Han, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 2, pp. 429-440
Open Access | Times Cited: 2
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database
Kazunaga Ishigaki, Yurie Tokito, Naminatsu Takahara, et al.
Journal of Gastroenterology (2024)
Open Access | Times Cited: 2
Kazunaga Ishigaki, Yurie Tokito, Naminatsu Takahara, et al.
Journal of Gastroenterology (2024)
Open Access | Times Cited: 2
Revolutionizing Breast Cancer Care: Cutting-Edge Breakthroughs and Future Frontiers in Precision Medicine
Muhammad Ali Qureshi, Muhammad Younas Khan, Ahmed Imran, et al.
(2024), pp. 115-141
Closed Access | Times Cited: 1
Muhammad Ali Qureshi, Muhammad Younas Khan, Ahmed Imran, et al.
(2024), pp. 115-141
Closed Access | Times Cited: 1
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer
Brenno Pastò, Riccardo Vida, Arianna Dri, et al.
The Breast (2024) Vol. 79, pp. 103859-103859
Closed Access | Times Cited: 1
Brenno Pastò, Riccardo Vida, Arianna Dri, et al.
The Breast (2024) Vol. 79, pp. 103859-103859
Closed Access | Times Cited: 1
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer
Grazia Castellano, Federica Giugliano, Giuseppe Curigliano, et al.
Current Opinion in Oncology (2023) Vol. 35, Iss. 6, pp. 479-490
Closed Access | Times Cited: 2
Grazia Castellano, Federica Giugliano, Giuseppe Curigliano, et al.
Current Opinion in Oncology (2023) Vol. 35, Iss. 6, pp. 479-490
Closed Access | Times Cited: 2
Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status
Izabela Łaczmańska, Rafał Matkowski, Stanisław Supplitt, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 3, pp. 501-510
Open Access
Izabela Łaczmańska, Rafał Matkowski, Stanisław Supplitt, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 3, pp. 501-510
Open Access
Development of a prognostic model related to homologous recombination deficiency in glioma based on multiple machine learning
Zhenyu Gong, Dairan Zhou, Haotian Shen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Zhenyu Gong, Dairan Zhou, Haotian Shen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Genetic heterogeneity and metabolic reprogramming in breast cancer
Yarkın Dolaş, Ayşe Buruş, Başak Çeltikçi
Acta Medica (2024) Vol. 55, Iss. 4, pp. 227-246
Open Access
Yarkın Dolaş, Ayşe Buruş, Başak Çeltikçi
Acta Medica (2024) Vol. 55, Iss. 4, pp. 227-246
Open Access
Pan-cancer Analysis of a Cytoskeleton Mobility related ARHGAP44 gene with Potential Implications in Cancer Prognosis Risk Prediction and Immune Landscape Modulation
Ningning Shen, Huijun Yang, Xuzhi Wang, et al.
Research Square (Research Square) (2023)
Open Access
Ningning Shen, Huijun Yang, Xuzhi Wang, et al.
Research Square (Research Square) (2023)
Open Access
Updates on Breast Cancer
Filippo Pesapane, Luca Nicosia, Enrico Cassano
Cancers (2023) Vol. 15, Iss. 22, pp. 5392-5392
Open Access
Filippo Pesapane, Luca Nicosia, Enrico Cassano
Cancers (2023) Vol. 15, Iss. 22, pp. 5392-5392
Open Access
Associaction between Prognosis, Carboplatin Treatmene Response and Homologous Recombination Deficiency Status in Early Triple-Negative Breast Cancer
Zheng Wang, Yujie Lu, Mengyuan Han, et al.
(2023)
Closed Access
Zheng Wang, Yujie Lu, Mengyuan Han, et al.
(2023)
Closed Access
Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer
Quanyi Long, Yunfei Wang, Hongjiang Li
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access
Quanyi Long, Yunfei Wang, Hongjiang Li
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access
